<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Ding D</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Coronary physiology measured by fractional flow reserve (FFR) is superior to angiography for assessing the efficacy of percutaneous coronary intervention (PCI). Yet, the clinical adoption of post-PCI FFR is limited. Murray law-based quantitative flow ratio (μQFR) may represent a promising alternative, as it can quickly compute FFR from a single angiographic view.&lt;h4>Objectives&lt;/h4>The authors aimed to investigate the potential role of post-PCI μQFR in predicting clinical outcomes.&lt;h4>Methods&lt;/h4>This was a post hoc blinded analysis of the FLAVOUR trial. Patients with angiographically intermediate lesions randomized 1:1 to receive FFR or intravascular ultrasound-guided PCI were included. Post-PCI μQFR was assessed in successfully stented vessels, blinded to clinical outco</pubmed_abstract><journal>JACC. Asia</journal><pagination>59-70</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11775804</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio: Post Hoc Analysis From FLAVOUR Trial.</pubmed_title><pmcid>PMC11775804</pmcid><pubmed_authors>Wijns W</pubmed_authors><pubmed_authors>Hahn JY</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Yoon MH</pubmed_authors><pubmed_authors>Ding D</pubmed_authors><pubmed_authors>Wu P</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Lee BK</pubmed_authors><pubmed_authors>Tang L</pubmed_authors><pubmed_authors>Koo BK</pubmed_authors><pubmed_authors>Jiang W</pubmed_authors><pubmed_authors>Yu W</pubmed_authors><pubmed_authors>Ahn SG</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Tahk SJ</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Ki YJ</pubmed_authors><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Shin ES</pubmed_authors><pubmed_authors>Pu J</pubmed_authors><pubmed_authors>Tu S</pubmed_authors><pubmed_authors>Doh JH</pubmed_authors><pubmed_authors>Kim W</pubmed_authors><pubmed_authors>He W</pubmed_authors><pubmed_authors>Kim U</pubmed_authors><pubmed_authors>Nam CW</pubmed_authors><pubmed_authors>Shi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio: Post Hoc Analysis From FLAVOUR Trial.</name><description>&lt;h4>Background&lt;/h4>Coronary physiology measured by fractional flow reserve (FFR) is superior to angiography for assessing the efficacy of percutaneous coronary intervention (PCI). Yet, the clinical adoption of post-PCI FFR is limited. Murray law-based quantitative flow ratio (μQFR) may represent a promising alternative, as it can quickly compute FFR from a single angiographic view.&lt;h4>Objectives&lt;/h4>The authors aimed to investigate the potential role of post-PCI μQFR in predicting clinical outcomes.&lt;h4>Methods&lt;/h4>This was a post hoc blinded analysis of the FLAVOUR trial. Patients with angiographically intermediate lesions randomized 1:1 to receive FFR or intravascular ultrasound-guided PCI were included. Post-PCI μQFR was assessed in successfully stented vessels, blinded to clinical outco</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T10:11:31.248Z</modification><creation>2025-04-05T23:35:08.625Z</creation></dates><accession>S-EPMC11775804</accession><cross_references><pubmed>39886193</pubmed><doi>10.1016/j.jacasi.2024.10.019</doi></cross_references></HashMap>